GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Molecular Regulation of Folate and Antifolate Transport

$261,415
Larry H. Matherly · Wayne State University · R01 · FY2019 · CA

Regulation of Tumorigenesis by the Perk Kinase

$261,383
J. Alan Diehl · University Of Pennsylvania · P01 · FY2014 · CA

Tumor Induced Dysregulation of T Cell Immunity

$261,383
James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA

Transcriptional Role of BRCA1 in Breast Cancer

$261,352
Wen-Hwa Lee · University Of California-Irvine · R01 · FY2012 · CA

Pre-Clinical Evaluation Core

$261,320
Mandi J. Lopez · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2025 · GM

Scr as a Therapeutic Target in Prostate Cancer Bone Metastases

$261,283
Gary E Gallick · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA

A2a receptor engagement promotes T cell tolerance

$261,258
Jonathan D Powell · Johns Hopkins University · R01 · FY2006 · CA

REGULATORY MECHANISMS CONTROLLING BREAST TISSUE DEVELOPMENT AND TRANSFORMATION

$261,147
Anthony N Imbalzano · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · CA

Computational Analysis Core

$261,128
Douglas A Lauffenburger · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Tungsten and Breast Cancer: Impact of the Tumor Microenvironment

$261,128
Alicia M. Bolt · University Of New Mexico Health Scis Ctr · P20 · FY2022 · GM

Role of Tumor in Therapeutic Response and Resistance

$261,117
Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA

Murine Neuroblastoma Models for Preclinical Therapeutics

$261,089
William A Weiss · University Of California, San Francisco · R01 · FY2016 · CA

Murine Neuroblastoma Models for Preclinical Therapeutics

$261,089
William A Weiss · University Of California, San Francisco · R01 · FY2015 · CA

MRI biosensors and complementary drug nanocarriers for effective image-guided drug delivery and early tumor response assessment of pediatric medulloblastomas

$261,083
Ethel Joso Ngen · Johns Hopkins University · R21 · FY2019 · HD

Innate and Adaptive Anti-Myeloma Immunity

$261,077
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2010 · CA

Intravital Microscopy Core

$261,045
Roberto Weigert · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

FAK and Pky2 in Determination of Glioblastoma Phenotype

$261,027
Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2007 · CA

Role of the UPR in myc-induced tumorigenesis

$260,995
Constantinos Koumenis · University Of Pennsylvania · P01 · FY2017 · CA

REGULATORY MECHANISMS CONTROLLING BREAST TISSUE DEVELOPMENT AND TRANSFORMATION

$260,959
Anthony N Imbalzano · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · CA

Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer

$260,958
Michael Cecchini · Yale University · K08 · FY2025 · CA

Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer

$260,958
Michael Cecchini · Yale University · K08 · FY2022 · CA

Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer

$260,958
Michael Cecchini · Yale University · K08 · FY2021 · CA

Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer

$260,958
Michael Cecchini · Yale University · K08 · FY2023 · CA

Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer

$260,958
Michael Cecchini · Yale University · K08 · FY2024 · CA

MUC1 in Therapy Resistance

$260,950
Michael A Hollingsworth · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · CA